Back to results
US 12,708,603 B2Granted
Treatment approach by targeted delivery of bioactive molecules bio modulated ceramics
AssigneeMoroxite AB
InventorsMagnus Tägil, Deepak Bushan Raina, Lars Åke Alvar Lidgren
Life of this patent
Estimating the term…
Abstract
Present invention relates to a novel composition administering pharma agents using a bi-phasic recruiting moiety.
Claims11
A method of treating a subject in need thereof with one or more first pharmaceutically active compounds at a site of the subject, the method comprising the steps of:
- i) administering to the site of the subject in need thereof a finely divided (particulate) material,
- wherein the finely divided material comprises a first material and a second material,
- wherein the first material comprises hydroxyapatite and consists of a mixture of micro-sized particles in a size range of about 10 μm, and nano-sized particles in a size range of about 40 nm to about 100 nm,
- wherein the ratio of micro-sized particles and nano-sized particles in the first materials is 1:1,
- wherein the second material is calcium sulphate hemi-hydrate and/or di-hydrate;
- ii) allowing a period of time to pass in order to provide for a sufficient amount of the second material to be bioresorbed such that the first material is exposed to the body;
- and
- iii) systemically administering the one or more first pharmaceutically active compounds after the period of time in (ii), such that the one or more first pharmaceutically active compounds bind to the first material at the site of the subject,
- wherein the one or more first pharmaceutically active compounds is a bisphosphonate selected from the group consisting of zoledronic acid, etidronic acid, clodronic acid, tiludronic acid, pamidronic acid, neridronic acid, olpadronic acid, alendronic acid, ibandronic acid, risendronic acid and a salt thereof.
6 more elements
Dependencies are inferred from the claim text.